Immunoenzyme Techniques
Research News and Information

Sunday, November 22, 2009

Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis.

29 Nov 2009 Endometrial cancer is the most common invasive gynecologic malignancy, yet molecular mechanisms and signaling pathways underlying its etiology and pathophysiology remain poorly characterized. We sought to define a functional role for the protein ... Read more...

Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.

29 Nov 2009 Our previous study has suggested that the cell cycle-related kinase (CCRK) is a putative candidate oncogene in glioblastoma tumorigenesis. The potential oncogenic role of CCRK and its clinical/prognostic significance, however, in ovarian carcinoma ... Read more...

Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model.

29 Nov 2009 Stage 4 neuroblastoma (NB) is a devastating childhood cancer whose poor outcome has remained essentially unchanged in the last 20 years. Receptor tyrosine kinases have important roles in the control of proliferation, differentiation and apoptosis of ... Read more...

Latest indexed articles for 'Immunoenzyme Techniques'

These are the very latest articles for this heading:

• Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis. 29 Nov 2009
• Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma. 29 Nov 2009
• Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model. 29 Nov 2009
• Downregulation of p21-activated kinase-1 inhibits the growth of gastric cancer cells involving cyclin B1. 29 Nov 2009
• Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. 29 Nov 2009
• Overexpression of low-density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice. 29 Nov 2009
• Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome. 29 Nov 2009
• The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity. 13 Nov 2009
• Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States. 13 Nov 2009
• Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. 13 Nov 2009
• Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three-dimensional carcinoma culture model. 13 Nov 2009
• Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. 13 Nov 2009
• Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. 13 Nov 2009
• Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. 13 Nov 2009
• Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma. 13 Nov 2009
• Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. 13 Nov 2009
• CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. 13 Nov 2009
• The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. 13 Nov 2009
• Identification of a chemokine receptor profile characteristic for mediastinal large B-cell lymphoma. 13 Nov 2009
• Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. 30 Oct 2009

See a longer list of these articles.

Technical information about 'Immunoenzyme Techniques'

Definition: Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.

Descriptor UI: D007124

Alternative terms: Immunoenzyme Techniques; Immunoenzyme Technique; Technique, Immunoenzyme; Techniques, Immunoenzyme; Immunoenzyme Technics; Immunoenzyme Technic; Technic, Immunoenzyme; Technics, Immunoenzyme; Peroxidase-Antiperoxidase Complex Technique; Peroxidase Antiperoxidase Complex Technique; Peroxidase-Antiperoxidase Complex Techniques; Technique, Peroxidase-Antiperoxidase Complex; Techniques, Peroxidase-Antiperoxidase Complex; Peroxidase-Antiperoxidase Complex Technic; Peroxidase Antiperoxidase Complex Technic; Peroxidase-Antiperoxidase Complex Technics; Technic, Peroxidase-Antiperoxidase Complex; Technics, Peroxidase-Antiperoxidase Complex; Peroxidase-Labeled Antibody Technique; Antibody Technique, Peroxidase-Labeled; Antibody Techniques, Peroxidase-Labeled; Peroxidase Labeled Antibody Technique; Peroxidase-Labeled Antibody Techniques; Technique, Peroxidase-Labeled Antibody; Techniques, Peroxidase-Labeled Antibody; Peroxidase-Labeled Antibody Technic; Antibody Technic, Peroxidase-Labeled; Antibody Technics, Peroxidase-Labeled; Peroxidase Labeled Antibody Technic; Peroxidase-Labeled Antibody Technics; Technic, Peroxidase-Labeled Antibody; Technics, Peroxidase-Labeled Antibody; Enzyme-Labeled Antibody Technique; Antibody Technique, Enzyme-Labeled; Antibody Techniques, Enzyme-Labeled; Enzyme Labeled Antibody Technique; Enzyme-Labeled Antibody Techniques; Technique, Enzyme-Labeled Antibody; Techniques, Enzyme-Labeled Antibody; Enzyme-Labeled Antibody Technic; Antibody Technic, Enzyme-Labeled; Antibody Technics, Enzyme-Labeled; Enzyme Labeled Antibody Technic; Enzyme-Labeled Antibody Technics; Technic, Enzyme-Labeled Antibody; Technics, Enzyme-Labeled Antibody; Antibody Enzyme Technique, Unlabeled; Antibody Enzyme Technic, Unlabeled; Enzyme Immunoassay; Enzyme Immunoassays; Immunoassays, Enzyme; Immunoassay, Enzyme; Immunoperoxidase Techniques; Immunoperoxidase Technique; Technique, Immunoperoxidase; Techniques, Immunoperoxidase; Immunoperoxidase Technics; Immunoperoxidase Technic; Technic, Immunoperoxidase; Technics, Immunoperoxidase;

Allowable Qualifiers: classification; economics; history; instrumentation; methods; standards; trends; utilization; veterinary; statistics & numerical data; ethics;

Tree Number: E01.450.495.410.350; E01.450.495.435.400; E05.478.594.410.350; E05.478.594.430.400; E05.601.495.350;

Online Note: use IMMUNOENZYME TECHNIQUES to search IMMUNOENZYME TECHNICS 1977-90

History Note: 91; was IMMUNOENZYME TECHNICS 1977-90

Technical Notes: coord with specific enzyme with no qualif (NIM) but do not bother to add PEROXIDASES or specific; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE is available